Rhumbline-Advisers

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-29
Total Holdings
4,182
Total Value
106905259736
Accession Number
0001115418-25-000005
Form Type
13F-HR/A
Manager Name
Rhumbline-Advisers
Data Enrichment
81% identified
3,407 identified775 unidentified

Holdings

4,182 positions • $106.9B total value
Manager:
Search and click to pin securities to the top
Page 177 of 210
LEXICON PHARMACEUTICALS, INC.
Shares:137.2K
Value:$63.3K
% of Portfolio:0.0% ($63.3K/$106.9B)
464287101
Shares:233
Value:$63.1K
% of Portfolio:0.0% ($63.1K/$106.9B)
XBiotech Inc.
Shares:19.5K
Value:$63.1K
% of Portfolio:0.0% ($63.1K/$106.9B)
Gildan Activewear Inc.
Shares:1.4K
Value:$62.9K
% of Portfolio:0.0% ($62.9K/$106.9B)
227047305
Shares:3.3K
Value:$62.7K
% of Portfolio:0.0% ($62.7K/$106.9B)
84652A102
Shares:10.9K
Value:$62.6K
% of Portfolio:0.0% ($62.6K/$106.9B)
00089H106
Shares:5.4K
Value:$62.2K
% of Portfolio:0.0% ($62.2K/$106.9B)
VALUE LINE INC
Shares:1.6K
Value:$62.1K
% of Portfolio:0.0% ($62.1K/$106.9B)
74589A101
Shares:25.8K
Value:$61.7K
% of Portfolio:0.0% ($61.7K/$106.9B)
35955T107
Shares:5.7K
Value:$61.2K
% of Portfolio:0.0% ($61.2K/$106.9B)
20854L108
Shares:793
Value:$61.1K
% of Portfolio:0.0% ($61.1K/$106.9B)
bluebird bio, Inc.
Shares:12.5K
Value:$61.1K
% of Portfolio:0.0% ($61.1K/$106.9B)
Kyverna Therapeutics, Inc.
Shares:31.6K
Value:$61.0K
% of Portfolio:0.0% ($61.0K/$106.9B)
Nautilus Biotechnology, Inc.
Shares:69.8K
Value:$60.0K
% of Portfolio:0.0% ($60.0K/$106.9B)
Critical Metals Corp.
Shares:43.0K
Value:$59.8K
% of Portfolio:0.0% ($59.8K/$106.9B)
233802107
Shares:4.8K
Value:$59.1K
% of Portfolio:0.0% ($59.1K/$106.9B)
Alto Neuroscience, Inc.
Shares:27.1K
Value:$58.6K
% of Portfolio:0.0% ($58.6K/$106.9B)
47110M208
Shares:1.5K
Value:$58.5K
% of Portfolio:0.0% ($58.5K/$106.9B)
TILLY'S, INC.
Shares:26.6K
Value:$58.5K
% of Portfolio:0.0% ($58.5K/$106.9B)
06279J109
Shares:5.0K
Value:$58.3K
% of Portfolio:0.0% ($58.3K/$106.9B)